View Agent
| Agent Info | |
| Agent: | SU5416 |
| Synonyms: | Semaxanib;Semaxinib;Semaxnib;Semoxind;S 8442;SU 5416;VEGF Receptor 2 Kinase Inhibitor III;InSolutionâ„¢ SU-5416;TSU-16;Semaxanib (USAN/INN);Methylene]-2H-indol-2-one;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one;1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl);1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one;3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone;3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole;3-(2,4-dimethylpyrrol-5-yl)methylidene-indolin-2-one;3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one;3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]indolin-2-one;3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one |
| Drug Status For Certain Diseases: | Multiple myeloma;HIV Infections …(phase II) |
| Classification: | antiangiogenic agent |
| Target: | Vascular endothelial growth factor |
| KEGG Pathway: | NA |
| Wiki Pathway: | NA |